- Home
- RDZN vs TELO Comparison
RDZN vs TELO Comparison
Compare RDZN & TELO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDZN
- TELO
- Stock Information
- Founded
- RDZN 2015
- TELO 2021
- Country
- RDZN United States
- TELO United States
- Employees
- RDZN N/A
- TELO N/A
- Industry
- RDZN Blank Checks
- TELO
- Sector
- RDZN Finance
- TELO
- Exchange
- RDZN Nasdaq
- TELO NYSE
- Market Cap
- RDZN 86.9M
- TELO 150.1M
- IPO Year
- RDZN N/A
- TELO 2024
- Fundamental
- Price
- RDZN $0.81
- TELO $4.82
- Analyst Decision
- RDZN Strong Buy
- TELO
- Analyst Count
- RDZN 1
- TELO 0
- Target Price
- RDZN $10.00
- TELO N/A
- AVG Volume (30 Days)
- RDZN 94.6K
- TELO 174.6K
- Earning Date
- RDZN 11-25-2024
- TELO 08-13-2024
- Dividend Yield
- RDZN N/A
- TELO N/A
- EPS Growth
- RDZN N/A
- TELO N/A
- EPS
- RDZN N/A
- TELO N/A
- Revenue
- RDZN $50,044,894.00
- TELO N/A
- Revenue This Year
- RDZN $60.41
- TELO N/A
- Revenue Next Year
- RDZN $44.39
- TELO N/A
- P/E Ratio
- RDZN N/A
- TELO N/A
- Revenue Growth
- RDZN 202.55
- TELO N/A
- 52 Week Low
- RDZN $0.80
- TELO $3.11
- 52 Week High
- RDZN $7.17
- TELO $20.72
- Technical
- Relative Strength Index (RSI)
- RDZN 28.36
- TELO 40.79
- Support Level
- RDZN $0.80
- TELO $4.69
- Resistance Level
- RDZN $1.01
- TELO $5.10
- Average True Range (ATR)
- RDZN 0.10
- TELO 0.39
- MACD
- RDZN -0.00
- TELO -0.14
- Stochastic Oscillator
- RDZN 2.12
- TELO 5.63
About RDZN Roadzen Inc.
Roadzen Inc is an insurance technology company on a mission to transform global auto insurance powered by advanced AI. Its clients comprise major insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.
About TELO TELOMIR PHARMACEUTICALS INC
Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells.